Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
MicuRx Pharmaceuticals, Inc.
4043
MicuRx Pharmaceuticals, Inc.
Health Care
Technology
Biotechnology
MicuRx is a clinicalstage biopharmaceutical company developing innovative antibiotics for multidrugresistant (MDR) bacterial infections including MRSA and VRE..
Suggest edits
Founded
2007
Raised
$90M
Follow us
Companies in the same industry
ConforMIS
BG Medicine
UniQure
Prime Genomics
Cempra
molecular assemblies
Apieron
Esperion Therapeutics
Empire Genomics
Prometic
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$55,000,000
Venture capital (Series C) - 2016
GP Healthcare Capital
GP TMT Capital
3E Bioventures Capital
+3
$25,000,000
Venture capital (Series B) - 2013
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$55,000,000
Venture capital (Series C)
yahoo
,
FinSMEs
,
prnasia
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
Health
